The market for Thoracolumbar Spine Devices Market is expected to reach USD$ 207.2 Mn in 2026.
Growing rates of spinal injuries such as degenerative disc disease or deformity have propelled the rise in investments in research activities by industrial players for the treatment and stabilization of the thoracolumbar spine. According to spinal cord.com, around 2,45,000 to 3,53,000 Americans were projected to live with spinal cord injuries in 2017. Traditional open surgeries require a prolonged hospital stay and are extensively painful. The need for new minimally invasive technology is increasing among healthcare providers and patients. Simplifying spinal surgeries is on the rise, thus contributing to the overall growth of the thoracolumbar spine devices market.
The FDA granted 510(k) clearance for the PEEK-OPTIMA HA enhanced vertebral body replacement system on December 7, 2017. Using spacers and endplates, the device allows for fine height and lordosis adjustments. It also consists of a hollow center and holes to accommodate an autograft and encourage the growth of new bone. On October 25, 2017, Zimmer Biomet Holdings, Inc. launched Vitality+ and Vital Spinal Fixation Systems in the United States. The Vital Spinal Fixation System offers a compact solution for degenerative thoracolumbar procedures. The advent of such new technologies and continuous research initiatives ensures lucrativeness throughout the period from 2018 to 2026.
Implant devices are expected to contribute significantly to the overall market owing to their lower side effects, improved quality of life, and high preference for the geriatric population, which is prone to spinal diseases. However, highly-priced devices and procedures, the requirement of skilled healthcare professionals, and the lack of structured reimbursement policies in low and middle-income economies would hamper the geographic expansion of the thoracolumbar spinal devices market and negatively affect the overall market growth.
The thoracolumbar spinal devices market comprises a competitive pool with various market leaders enjoying supremacy. Partnerships and acquisitions render the market competitive and challenge the entry of new emerging market players. On September 7, 2017, NuVasive, Inc. acquired Vetera Spine. The acquisition reflected NuVasive’s commitment to expanding its product portfolio and marked its position as a leader in spinal devices. Other key industrial players enjoying a dominant position in this market are Aesculap Implant Systems, LLC, B. Braun Melsungen AG, DePuy Synthes, Inc., Globus Medical, Inc., Invibo Ltd., Medtronic Plc., Stryker Corp., and Zimmer Biomet Holdings, Inc.
The market for Thoracolumbar Spine Devices Market is expected to reach USD$ 207.2 Mn in 2026.
The Thoracolumbar Spine Devices Market is expected to see significant CAGR growth over the coming years, at 6.0%.
The report is forecasted from 2018 -2026.
The base year of this report is 2017.
Implant Systems, LLC, B. Braun Melsungen AG, DePuy Synthes, Inc., Globus Medical, Inc., Invibo Ltd., Medtronic Plc., Stryker Corp., and Zimmer Biomet Holdings. are some of the major players in the global market.